Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Whitney

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Opinion in HIV and AIDS|May 15, 2024
Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directionsJina Lee, James B Whitney
Current Opinion in Infectious Diseases|April 20, 2004
Live attenuated HIV vaccines: pitfalls and prospectsJames B Whitney, Ruth M Ruprecht
Virus Research|August 17, 2017
Zika virus research modelsJessica L Kublin, James B Whitney
Retrovirology|December 23, 2006
Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIVmac239James B Whitney, Mark A Wainberg
Advances in Experimental Medicine and Biology|July 22, 2018
In Vitro and In Vivo Models of HIV LatencyJames B Whitney, R Brad Jones
The Journal of Infectious Diseases|December 22, 2017
Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic DevelopmentChrista E Osuna, James B Whitney
Retrovirology|July 5, 2007
Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genomeJames B Whitney, Mark A Wainberg
Plos One|May 3, 2011
Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replicationJames B Whitney, Mohammed Asmal, Ralf Geiben-Lynn
Viruses|March 28, 2026
Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus MacaquesSo-Yon Lim, Ma Luo, James B Whitney
AIDS Reviews|October 7, 2011
Evolutionary mechanisms of retroviral persistenceJames B Whitney, So-Yon Lim, Mark A Wainberg
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Opinion in HIV and AIDS|May 15, 2024
Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directionsJina Lee, James B Whitney
Current Opinion in Infectious Diseases|April 20, 2004
Live attenuated HIV vaccines: pitfalls and prospectsJames B Whitney, Ruth M Ruprecht
Virus Research|August 17, 2017
Zika virus research modelsJessica L Kublin, James B Whitney
Retrovirology|December 23, 2006
Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIVmac239James B Whitney, Mark A Wainberg
Advances in Experimental Medicine and Biology|July 22, 2018
In Vitro and In Vivo Models of HIV LatencyJames B Whitney, R Brad Jones
The Journal of Infectious Diseases|December 22, 2017
Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic DevelopmentChrista E Osuna, James B Whitney
Retrovirology|July 5, 2007
Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genomeJames B Whitney, Mark A Wainberg
Plos One|May 3, 2011
Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replicationJames B Whitney, Mohammed Asmal, Ralf Geiben-Lynn
Viruses|March 28, 2026
Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus MacaquesSo-Yon Lim, Ma Luo, James B Whitney
AIDS Reviews|October 7, 2011
Evolutionary mechanisms of retroviral persistenceJames B Whitney, So-Yon Lim, Mark A Wainberg
Pageof 6